Ultrasonography-guided single-port transaxillary endoscopic excision for breast fibroadenoma: a retrospective comparative study of technical feasibility and early outcomes Authors: Chao Wang, He Jiang, Xiaoyue Zhang, Xin Miao, Feng Zhao, Xiangguo Dang Published: 2026 ABSTRACT BackgroundIntraoperative ultrasonography may compensate for the loss of direct palpation during concealed transaxillary endoscopic excision of breast fibroadenoma. This study assessed the feasibility and early outcomes of this ultrasound-guided remote access technique compared with conventional open excision.MethodsTwenty women with breast fibroadenoma underwent single-port transaxillary endoscopic excision with intraoperative ultrasonographic guidance (n = 10) or conventional open excision (n = 10). Outcomes included operative time, blood loss, incision length, postoperative pain, hospital stay, complications, residual lesion on postoperative ultrasonography, and selected BREAST-Q domains.ResultsEndoscopic excision was completed in all patients without conversion. In all endoscopic cases, intraoperative ultrasonography was used to re-identify the target lesion after working-space creation, and repeat ultrasonography confirmed no sonographically visible residual lesion after tumor removal. No residual lesion was detected on postoperative ultrasonography in either group. Compared with open excision, the endoscopic approach showed longer operative time (mean difference [MD], 64.8 min; 95% CI, 42.2 to 87.4; Hedges g = 2.62), higher 24-hour postoperative pain scores (MD, 2.3 points; 95% CI, 1.2 to 3.4; Hedges g = 1.97), and longer institution-specific hospital stay (MD, 2.0 days; 95% CI, 1.0 to 3.0; Hedges g = 1.81). Estimated intraoperative blood loss was lower in the endoscopic group (MD, -10.3 mL; 95% CI, -14.2 to -6.4; Hedges g = -2.44), although the absolute difference was small and should not be interpreted as a major clinical advantage. Incision length and 30-day complication rates showed limited between-group separation. At 3 months, patient-reported psychosocial well-being, breast satisfaction, and scar satisfaction scores were numerically higher in the endoscopic group.ConclusionIn this small retrospective proof-of-concept cohort, single-port transaxillary endoscopic excision with intraoperative ultrasonographic guidance was technically feasible in selected patients with breast fibroadenoma and enabled complete excision without sonographically visible residual lesions. However, this concealed-access approach involved longer operative time, higher early postoperative pain, and longer institution-specific hospitalization than conventional open excision. Its potential role should therefore be framed as a selected cosmetic and image-guided surgical option rather than a broadly superior alternative to open excision. Introduction Breast fibroadenoma is the most frequently diagnosed benign breast tumor in adolescent and young adult women [1–4]. Although benign from an oncologic standpoint, fibroadenomas often require surgical intervention because of progressive enlargement, local symptoms, diagnostic uncertainty, or patient anxiety [5, 6]. In this setting, the primary surgical objective is complete lesion removal with preservation of surrounding breast tissue and contour. Conventional open excision remains a straightforward and reliable approach for fibroadenoma removal. However, it usually requires an incision on the breast surface, commonly along the periareolar border or directly over the lesion, which may result in visible scarring. This issue is particularly relevant in young women, in whom breast appearance and scar visibility may strongly influence treatment acceptance and postoperative satisfaction. To reduce visible scarring, several endoscopic techniques for benign breast tumors have been developed, including transaxillary and inframammary approaches [7–9]. These techniques offer concealed access and may improve postoperative breast surface appearance. At the same time, endoscopic surgery involves remote access, working-space creation, and indirect lesion handling, which may increase procedural complexity and operative burden compared with open excision. Most previous comparative studies of endoscopic and open excision for benign breast lesions have focused on perioperative outcomes or cosmetic benefit [10, 11]. Fewer studies have emphasized the technical workflow of the procedure, including lesion localization, completeness of excision, early safety, and the practical trade-offs associated with a remote access approach. In fibroadenoma surgery, intraoperative ultrasonographic guidance may be particularly useful because lesion depth and orientation may be difficult to judge after creation of a transaxillary working space. A concealed transaxillary approach may reduce visible breast scarring by avoiding an incision on the breast surface, but it also creates a technical challenge because intraoperative lesion identification cannot rely on direct palpation. For fibroadenomas located within glandular tissue, lesion depth, orientation, and completeness of excision may be more difficult to judge after creation of a remote working space than during open surgery. Therefore, we incorporated routine intraoperative ultrasonographic guidance into a single-port transaxillary endoscopic workflow to provide real-time lesion localization and resection confirmation. This study primarily evaluated the feasibility, completeness of excision, and early safety of this ultrasound-guided remote access technique in selected patients with breast fibroadenoma. Methods Study design and patients This retrospective comparative study screened 22 otherwise eligible female patients with pathologically confirmed breast fibroadenoma who underwent surgical excision at our institution between January 2025 and January 2026, including 10 patients treated with endoscopic excision and 12 patients treated with open excision. Eligibility criteria were: (1) pathologically confirmed breast fibroadenoma; (2) lesion diameter ≥ 1.0 cm; and (3) complete clinical and follow-up data. Patients with suspected or confirmed malignancy, previous breast surgery, pregnancy or lactation, or bilateral procedures were excluded. With regard to the requirement for complete clinical and follow-up data, no patient in the endoscopic group was excluded, whereas two patients in the open excision group were excluded because postoperative follow-up could not be completed. Finally, 20 patients with complete clinical and follow-up data were included in the final analysis, including 10 patients in the endoscopic excision group and 10 patients in the open excision group. Surgical technique Endoscopic excision Patients in the endoscopic group were placed in the supine position under general anesthesia with endotracheal intubation. The ipsilateral arm was abducted to approximately 90° to optimize exposure of the axilla. The ipsilateral arm was wrapped with sterile drapes and suspended to the anesthesia frame to increase the axillary working space and facilitate endoscopic instrument manipulation. A single concealed incision was created within the natural axillary crease, with the final incision length determined by lesion size and specimen retrieval requirements. Representative clinical, ultrasonographic, and specimen findings are shown in Fig. 1. After division of the skin and subcutaneous tissue, a working space was developed along the plane superficial to the pectoralis major fascia toward the target lesion. Fig. 1Representative clinical, ultrasonographic, and specimen findings of single-port transaxillary endoscopic excision of breast fibroadenoma with intraoperative ultrasonographic guidance. A, B Preoperative breast appearance and lesion marking. C Concealed axillary single-port access during the transaxillary endoscopic procedure. D Postoperative frontal breast appearance showing absence of a visible breast-surface incision. E Postoperative axillary appearance showing concealment of the incision within the natural axillary crease. F Retrieved tumor specimens after transaxillary endoscopic excision. G, H Intraoperative ultrasonographic localization and confirmation of the lesion/operative bed. I Gross specimen appearance after retrieval Representative clinical, ultrasonographic, and specimen findings of single-port transaxillary endoscopic excision of breast fibroadenoma with intraoperative ultrasonographic guidance. A, B Preoperative breast appearance and lesion marking. C Concealed axillary single-port access during the transaxillary endoscopic procedure. D Postoperative frontal breast appearance showing absence of a visible breast-surface incision. E Postoperative axillary appearance showing concealment of the incision within the natural axillary crease. F Retrieved tumor specimens after transaxillary endoscopic excision. G, H Intraoperative ultrasonographic localization and confirmation of the lesion/operative bed. I Gross specimen appearance after retrieval The operative cavity was established using CO₂ insufflation at 10 mmHg. The retromammary space was then expanded under endoscopic visualization to expose the posterior surface of the breast parenchyma. A 30° endoscope was used together with standard endoscopic instruments, including grasping forceps, an electrocautery hook, and a suction-irrigation device. After establishment of the retromammary working space, intraoperative ultrasonography was employed as a routine step rather than an optional adjunct. The lesion was re-identified sonographically from the breast surface to determine its depth, projection, and relationship to the planned endoscopic dissection plane; these ultrasound findings were used to guide the direction and extent of parenchymal dissection. The lesion was then dissected circumferentially under endoscopic vision with preservation of the surrounding breast parenchyma and the overlying skin flap, and was removed en bloc whenever possible. If lesion localization, orientation of the dissection plane, or completeness of resection was uncertain at any point, repeat intraoperative ultrasonographic assessment was performed. No methylene blue or other dye-based marker was used for lesion delineation. Dye injection was avoided because it may leave visible staining on the breast skin or subcutaneous tissue and because diffusion of dye into the surrounding glandular tissue may obscure the interface between the fibroadenoma and adjacent parenchyma. Intraoperative localization therefore relied on ultrasonographic guidance and, when needed, temporary needle localization. During the relevant steps of the procedure, an assistant performed ultrasonographic scanning from the breast surface to identify the lesion, assess its depth and projection, and communicate the findings to the operating surgeon. When lesion position or dissection direction was uncertain, a needle attached to a 10-mL syringe was inserted percutaneously from the breast surface under ultrasonographic guidance into the tissue adjacent to the tumor edge. The needle served as a temporary mechanical landmark for endoscopic orientation; no dye was injected. Ultrasonography was repeated at key steps and whenever localization or completeness of excision was uncertain. After tumor removal, ultrasonography was again performed to confirm that no sonographically visible residual lesion remained in the operative bed. After complete mobilization, the specimen was placed into a sterile protective specimen bag and retrieved intact through the single axillary incision. No additional breast-surface incision was required for specimen delivery. The operative field was then irrigated, hemostasis was confirmed under endoscopic visualization, and a drainage tube was placed within the operative cavity. The axillary incision was closed, and elastic compression dressing was applied to the surgical area. Open excision Open excision was performed through a direct breast incision, most commonly along the periareolar border or in a radial orientation over the lesion. The tumor was enucleated along its capsule under direct vision. In both groups, the operative goal was complete excision of the fibroadenoma with preservation of surrounding breast tissue and contour. Technical standardization To reduce procedural heterogeneity, all procedures were performed by the same surgical team. Endoscopic cases followed the same transaxillary single-incision workflow with routine intraoperative ultrasonographic localization. Intraoperative decision-making regarding repeat ultrasonographic confirmation, extent of dissection, and specimen retrieval followed a consistent operative strategy throughout the study period. Outcome measures The primary outcomes of interest were technical and perioperative parameters, including operative time, intraoperative blood loss, incision length, completeness of excision, residual lesion on postoperative ultrasonography, and postoperative complications. Operative time was defined as the interval from skin incision to skin closure. Intraoperative blood loss was estimated by the attending anesthesiologist and surgical team based on suction canister volume and surgical sponges. Incision length was measured in centimeters along the skin surface. Postoperative recovery outcomes included pain score and length of hospital stay. Postoperative pain was assessed using a 10-point visual analog scale (VAS), with 0 indicating no pain and 10 indicating the worst pain imaginable, at 24 h after surgery. Length of hospital stay was calculated as the number of days from the day of surgery to discharge. All excised specimens underwent histopathological examination to confirm fibroadenoma. Postoperative breast ultrasonography was performed according to institutional routine to assess for residual lesions at the operative site. Recorded postoperative complications included postoperative bleeding, hematoma, seroma, superficial, deep, and organ/space surgical site infection, wound dehiscence, delayed wound healing/poor healing, skin or nipple-areolar ischemia, nipple necrosis, subcutaneous emphysema, sensory disturbance/numbness, and persistent pain requiring additional treatment. A derived 30-day overall complication endpoint was defined as the occurrence of any recorded complication within 30 days after surgery. Patient-reported psychosocial and aesthetic outcomes Patient-reported psychosocial and aesthetic outcomes were assessed using selected BREAST-Q domains relevant to benign breast surgery, including psychosocial well-being, satisfaction with breast appearance, and scar satisfaction [12, 13]. Psychosocial well-being was assessed preoperatively and at 3 months postoperatively to allow evaluation of perioperative psychosocial change, whereas satisfaction with breast appearance and scar satisfaction were assessed at 3 months. The same domains, response options, and scoring approach were applied in both groups. Scores were transformed to a 0-100 scale, with higher scores indicating better psychosocial well-being, greater satisfaction with breast appearance, or greater satisfaction with scars. Statistical analysis Statistical analyses followed an estimation-focused approach appropriate for a small exploratory cohort. Continuous variables were summarized as mean ± standard deviation and categorical variables as counts and percentages. Normality of continuous variables was assessed using the Shapiro-Wilk test. Between-group comparisons for continuous variables were performed using the independent-samples Student’s t-test when distributional assumptions were acceptable. Results for continuous outcomes are reported as absolute mean differences with 95% confidence intervals. Categorical variables were compared using the chi-square test or Fisher’s exact test, as appropriate; binary complication outcomes are reported as absolute risk differences with 95% confidence intervals. Complete excision was summarized descriptively because it occurred in all patients in both groups. Standardized effect sizes for continuous outcomes were reported as Hedges g. For the patient-reported psychosocial and aesthetic outcomes, emphasis was placed on descriptive between-group comparisons at baseline and at 3 months. Given the exploratory nature of this small retrospective cohort, statistical testing was performed for descriptive purposes only. Emphasis was placed on effect estimates, 95% confidence intervals, standardized effect sizes, and clinical interpretation rather than on formal hypothesis testing or statistical significance thresholds. Statistical analyses were conducted using SPSS version 25.0. Results Baseline characteristics Baseline characteristics are summarized in Table 1. The two groups were generally comparable in age, BMI, maximum tumor diameter, and number of tumors per patient. The endoscopic group had a numerically larger mean maximum tumor diameter than the open group (3.7 ± 1.4 cm vs. 2.9 ± 1.5 cm; mean difference, 0.85 cm; 95% CI, − 0.51 to 2.21), suggesting possible treatment selection in this small non-randomized cohort. Table 1Baseline characteristicsVariableEndoscopic group (n = 10)Open group (n = 10)SMDAge, years25.3 ± 9.127.9 ± 5.9-0.34BMI, kg/m²22.3 ± 3.422.5 ± 4.3-0.04Maximum tumor diameter, cm3.7 ± 1.42.9 ± 1.50.59Number of tumors1.4 ± 0.71.3 ± 0.50.17Continuous variables are presented as mean ± SD. BMI body mass index, SMD standardized mean difference Table 1Baseline characteristicsVariableEndoscopic group (n = 10)Open group (n = 10)SMDAge, years25.3 ± 9.127.9 ± 5.9-0.34BMI, kg/m²22.3 ± 3.422.5 ± 4.3-0.04Maximum tumor diameter, cm3.7 ± 1.42.9 ± 1.50.59Number of tumors1.4 ± 0.71.3 ± 0.50.17Continuous variables are presented as mean ± SD. BMI body mass index, SMD standardized mean difference Baseline characteristics Continuous variables are presented as mean ± SD. BMI body mass index, SMD standardized mean difference Technical feasibility and intraoperative outcomes Technical and intraoperative outcomes are summarized in Table 2. Endoscopic excision was successfully completed in all 10 patients without conversion to open surgery. In all endoscopic cases, intraoperative ultrasonography was used after creation of the transaxillary working space to re-identify the target lesion and support endoscopic localization and dissection planning. No case required conversion or an additional breast surface incision because of failed lesion localization. In all 10 endoscopic cases, the specimen was retrieved intact through the single axillary incision after placement in a sterile protective specimen bag. No case required piecemeal extraction or an additional breast-surface incision for specimen delivery. Regarding lesion location in the endoscopic group, three patients had lesions located in the upper inner quadrant and one patient had a lesion located in the lower inner quadrant. All of these lesions were successfully excised and retrieved intact through the single axillary incision, without conversion to open surgery or an additional breast-surface incision. After tumor removal, repeat intraoperative ultrasonography confirmed no sonographically visible residual lesion in the operative bed in all endoscopic cases. Compared with open excision, the endoscopic approach showed longer operative time (137.0 ± 28.8 min vs. 72.2 ± 17.0 min; mean difference [MD], 64.8 min; 95% CI, 42.2 to 87.4; Hedges g = 2.62). Estimated intraoperative blood loss was lower in the endoscopic group (7.4 ± 2.3 mL vs. 17.7 ± 5.2 mL; MD, − 10.3 mL; 95% CI, − 14.2 to − 6.4; Hedges g = − 2.44), although the absolute difference was small in clinical terms. Incision length showed limited between-group separation (4.2 ± 0.8 cm vs. 3.8 ± 1.2 cm; MD, 0.4 cm; 95% CI, − 0.6 to 1.4; Hedges g = 0.37). Table 2Perioperative outcomesOutcomeEndoscopic group (n = 10)Open group (n = 10)Mean difference (E − O)95% CIP valueHedges gOperative time, min137.0 ± 28.872.2 ± 17.064.842.2 to 87.4< 0.0012.62Blood loss, mL7.4 ± 2.317.7 ± 5.2-10.3-14.2 to -6.4< 0.001-2.44Incision length, cm4.2 ± 0.83.8 ± 1.20.4-0.6 to 1.40.4000.37Hospital stay, days5.7 ± 1.33.7 ± 0.82.01.0 to 3.0< 0.0011.81Postoperative VAS pain score5.7 ± 0.93.4 ± 1.32.31.2 to 3.4< 0.0011.97Data are presented as mean ± SD. Effect estimates are expressed as absolute mean differences with 95% CIs. VAS visual analogue scale, CI confidence interval. P values are reported for descriptive purposes only and should not be interpreted as confirmatory hypothesis testing Table 2Perioperative outcomesOutcomeEndoscopic group (n = 10)Open group (n = 10)Mean difference (E − O)95% CIP valueHedges gOperative time, min137.0 ± 28.872.2 ± 17.064.842.2 to 87.4< 0.0012.62Blood loss, mL7.4 ± 2.317.7 ± 5.2-10.3-14.2 to -6.4< 0.001-2.44Incision length, cm4.2 ± 0.83.8 ± 1.20.4-0.6 to 1.40.4000.37Hospital stay, days5.7 ± 1.33.7 ± 0.82.01.0 to 3.0< 0.0011.81Postoperative VAS pain score5.7 ± 0.93.4 ± 1.32.31.2 to 3.4< 0.0011.97Data are presented as mean ± SD. Effect estimates are expressed as absolute mean differences with 95% CIs. VAS visual analogue scale, CI confidence interval. P values are reported for descriptive purposes only and should not be interpreted as confirmatory hypothesis testing Perioperative outcomes Data are presented as mean ± SD. Effect estimates are expressed as absolute mean differences with 95% CIs. VAS visual analogue scale, CI confidence interval. P values are reported for descriptive purposes only and should not be interpreted as confirmatory hypothesis testing Multiple fibroadenomas were present in 3 patients in the endoscopic group and 3 patients in the open excision group. In the endoscopic group, all lesions were removed through the single axillary incision, and no additional breast-surface incision was required. Completeness of excision and short-term safety All patients achieved complete tumor excision, and no residual lesions were detected on postoperative ultrasonography; the complete excision rate was 100% in both groups. Postoperative complications were infrequent in both groups (Table 3). The derived 30-day overall complication rate was 20.0% (2/10) in the endoscopic group and 30.0% (3/10) in the open group, corresponding to an absolute risk difference of − 10.0% (95% CI, − 43.5% to 26.5%). The confidence interval was wide, and these complication data should be interpreted as descriptive because of the small sample size. Some patients experienced more than one postoperative event. Table 3Postoperative complicationsOutcomeEndoscopic group (n = 10)Open group (n = 10)Risk difference (E − O)95% CIP valueAny 30-day complication2 (20.0)3 (30.0)-10.0%-43.5% to 26.5%1.000Postoperative bleeding1 (10.0)1 (10.0)0.0%-31.5% to 31.5%1.000Hematoma2 (20.0)1 (10.0)10.0%-23.6% to 42.1%1.000Superficial surgical site infection1 (10.0)1 (10.0)0.0%-31.5% to 31.5%1.000Delayed wound healing1 (10.0)2 (20.0)-10.0%-42.1% to 23.6%1.000Data are presented as n (%). Individual patients could experience more than one postoperative complication; therefore, the sum of individual complication events may exceed the number of patients with any 30-day complication. P values were calculated using Fisher’s exact test and are provided for descriptive purposes only. Because of the small sample size and sparse events, complication comparisons should be interpreted cautiously. Effect estimates are expressed as absolute risk differences with 95% confidence intervals. The following complications were not observed in either group: seroma, wound dehiscence, deep infection, organ/space infection, skin ischemia, nipple necrosis, subcutaneous emphysema, sensory disturbance, and persistent pain requiring additional treatment Table 3Postoperative complicationsOutcomeEndoscopic group (n = 10)Open group (n = 10)Risk difference (E − O)95% CIP valueAny 30-day complication2 (20.0)3 (30.0)-10.0%-43.5% to 26.5%1.000Postoperative bleeding1 (10.0)1 (10.0)0.0%-31.5% to 31.5%1.000Hematoma2 (20.0)1 (10.0)10.0%-23.6% to 42.1%1.000Superficial surgical site infection1 (10.0)1 (10.0)0.0%-31.5% to 31.5%1.000Delayed wound healing1 (10.0)2 (20.0)-10.0%-42.1% to 23.6%1.000Data are presented as n (%). Individual patients could experience more than one postoperative complication; therefore, the sum of individual complication events may exceed the number of patients with any 30-day complication. P values were calculated using Fisher’s exact test and are provided for descriptive purposes only. Because of the small sample size and sparse events, complication comparisons should be interpreted cautiously. Effect estimates are expressed as absolute risk differences with 95% confidence intervals. The following complications were not observed in either group: seroma, wound dehiscence, deep infection, organ/space infection, skin ischemia, nipple necrosis, subcutaneous emphysema, sensory disturbance, and persistent pain requiring additional treatment Postoperative complications Data are presented as n (%). Individual patients could experience more than one postoperative complication; therefore, the sum of individual complication events may exceed the number of patients with any 30-day complication. P values were calculated using Fisher’s exact test and are provided for descriptive purposes only. Because of the small sample size and sparse events, complication comparisons should be interpreted cautiously. Effect estimates are expressed as absolute risk differences with 95% confidence intervals. The following complications were not observed in either group: seroma, wound dehiscence, deep infection, organ/space infection, skin ischemia, nipple necrosis, subcutaneous emphysema, sensory disturbance, and persistent pain requiring additional treatment Short-term postoperative recovery Short-term postoperative recovery outcomes are summarized in Table 2. The endoscopic group showed a longer institution-specific hospital stay than the open excision group (5.7 ± 1.3 days vs. 3.7 ± 0.8 days; mean difference, 2.0 days; 95% CI, 1.0 to 3.0; Hedges g = 1.81). Postoperative pain at 24 h was higher after endoscopic excision (VAS 5.7 ± 0.9 vs. 3.4 ± 1.3; mean difference, 2.3 points; 95% CI, 1.2 to 3.4; Hedges g = 1.97). Because discharge after endoscopic excision was closely linked to postoperative drain management in our institution, length of stay should be interpreted as an institution-specific management endpoint rather than a direct measure of postoperative recovery. Patient-reported psychosocial and aesthetic outcomes Patient-reported psychosocial and aesthetic outcomes are summarized in Table 4. Baseline psychosocial well-being was comparable between groups (81.6 ± 3.0 vs. 81.8 ± 2.3; MD, − 0.2; 95% CI, − 2.8 to 2.4). At 3 months, the endoscopic group showed numerically higher psychosocial well-being (95.3 ± 1.2 vs. 92.0 ± 2.2; MD, 3.3; 95% CI, 1.6 to 5.0; Hedges g = 1.79), breast satisfaction (91.8 ± 1.9 vs. 86.5 ± 4.9; MD, 5.3; 95% CI, 1.7 to 8.9; Hedges g = 1.38), and scar satisfaction (93.4 ± 2.8 vs. 90.0 ± 2.8; MD, 3.4; 95% CI, 0.8 to 6.0; Hedges g = 1.17). Given the small sample size, short follow-up, and non-randomized treatment allocation, these patient-reported differences should be interpreted as exploratory signals rather than confirmatory evidence of superiority. Table 4Between-group comparison of patient-reported psychosocial and aesthetic outcomesOutcomeEndoscopic group (n = 10)Open group (n = 10)Mean difference (E − O)95% CIP valueHedges gPsychosocial well-being, baseline81.6 ± 3.081.8 ± 2.3-0.2-2.8 to 2.40.871-0.07Psychosocial well-being, 3 months95.3 ± 1.292.0 ± 2.23.31.6 to 5.0< 0.0011.79Scar satisfaction, 3 months93.4 ± 2.890.0 ± 2.83.40.8 to 6.00.0141.17Breast satisfaction, 3 months91.8 ± 1.986.5 ± 4.95.31.7 to 8.90.0081.38Data are presented as mean ± SD. Baseline psychosocial well-being is shown to document preoperative comparability. CI confidence interval. P values are reported for descriptive purposes only and should not be interpreted as confirmatory hypothesis testing Table 4Between-group comparison of patient-reported psychosocial and aesthetic outcomesOutcomeEndoscopic group (n = 10)Open group (n = 10)Mean difference (E − O)95% CIP valueHedges gPsychosocial well-being, baseline81.6 ± 3.081.8 ± 2.3-0.2-2.8 to 2.40.871-0.07Psychosocial well-being, 3 months95.3 ± 1.292.0 ± 2.23.31.6 to 5.0< 0.0011.79Scar satisfaction, 3 months93.4 ± 2.890.0 ± 2.83.40.8 to 6.00.0141.17Breast satisfaction, 3 months91.8 ± 1.986.5 ± 4.95.31.7 to 8.90.0081.38Data are presented as mean ± SD. Baseline psychosocial well-being is shown to document preoperative comparability. CI confidence interval. P values are reported for descriptive purposes only and should not be interpreted as confirmatory hypothesis testing Between-group comparison of patient-reported psychosocial and aesthetic outcomes Data are presented as mean ± SD. Baseline psychosocial well-being is shown to document preoperative comparability. CI confidence interval. P values are reported for descriptive purposes only and should not be interpreted as confirmatory hypothesis testing Discussion This small retrospective proof-of-concept study suggests that single-port transaxillary endoscopic excision with intraoperative ultrasonographic guidance is technically feasible in selected patients with breast fibroadenoma. The findings should be interpreted descriptively rather than as confirmatory evidence of superiority over open excision. In this cohort, all endoscopic procedures were completed without conversion, and no postoperative residual lesions were detected on ultrasonography. However, the endoscopic approach was associated with longer operative time, higher early postoperative pain, and longer institution-specific hospitalization. These findings indicate that this concealed-access approach involves clear short-term perioperative trade-offs. A key technical feature of the endoscopic approach is the combination of remote axillary access and intraoperative ultrasonographic localization. Once a working space has been created away from the breast surface, direct palpation of the lesion becomes limited, and real-time identification of lesion depth, orientation, and dissection plane may be less intuitive than in conventional open surgery. In this setting, intraoperative ultrasonography can serve as a practical adjunct for confirming lesion position, guiding dissection, and verifying completeness of resection. This image-guided component is particularly valuable for fibroadenomas embedded within glandular tissue at variable depths, especially when en bloc removal is desired while minimizing disruption of surrounding breast parenchyma. A practical aspect of this workflow is that localization did not depend on dye marking. Instead, repeated ultrasonographic assessment and temporary needle localization provided orientation during remote endoscopic dissection. When the lesion position or dissection direction was uncertain, a needle attached to a 10-mL syringe was inserted percutaneously from the breast surface under ultrasonographic guidance into the tissue adjacent to the tumor edge. This needle served as a temporary mechanical landmark for endoscopic orientation, and no dye was injected. This approach may reduce the risk of losing the lesion after creation of the working space while avoiding potential dye-related skin staining or diffusion-related blurring of the tumor-parenchyma interface. From a technical standpoint, the procedure depends on three reproducible elements: reliable creation of the retromammary working space, image-guided lesion localization after loss of direct palpation, and controlled en bloc dissection through a single remote access incision. These steps likely represent the core determinants of procedural success in this setting. However, the present findings also indicate that these technical advantages are accompanied by measurable short-term costs. Compared with conventional open excision, the endoscopic approach required substantially longer operative time and was associated with greater pain at 24 h and longer hospitalization. Estimated intraoperative blood loss was numerically lower in the endoscopic group and small in absolute terms. These findings are consistent with the additional procedural steps inherent to remote access surgery, including working-space creation, broader subcutaneous dissection, endoscopic manipulation through a confined access route, and repeated imaging-based localization when required. The observed length of hospital stay should be interpreted as an institution-specific management endpoint rather than as a direct indicator of delayed physiological recovery. In our practice, patients undergoing open excision, particularly those with multiple lesions, were admitted for short-term postoperative observation to monitor early events such as postoperative bleeding or hematoma. When no obvious discomfort or early complication was observed, these patients could generally be discharged on the first postoperative day. By contrast, patients undergoing endoscopic excision routinely received a drain because creation of the retromammary working space leaves a potential postoperative dead space, which may increase the risk of fluid accumulation. Discharge after endoscopic excision was therefore closely linked to drain output and drain removal criteria. Accordingly, the longer hospital stay in the endoscopic group mainly reflects our local drain-based postoperative management pathway and should not be interpreted as evidence of poor postoperative recovery. In many healthcare settings, excision of benign breast lesions is performed as a same-day or outpatient procedure; therefore, both the absolute length-of-stay values and the between-group difference have limited external generalizability. The observed difference in estimated intraoperative blood loss should be interpreted with particular caution. Although blood loss was numerically lower in the endoscopic group (7.4 mL vs. 17.7 mL), the absolute difference was approximately 10 mL, and both values were very low in the context of benign breast surgery. Therefore, this finding should not be interpreted as a clinically meaningful advantage of the endoscopic approach. The lower estimated blood loss may reflect the enclosed insufflation environment, magnified endoscopic visualization, and controlled dissection, but it does not by itself support clinical superiority. In practical terms, the longer operative time, higher early postoperative pain, and institution-specific longer hospitalization are more relevant perioperative considerations than this small blood loss difference. The higher early postoperative pain score after endoscopic excision should also be interpreted as an important short-term disadvantage of the technique. This finding may be related to the broader subcutaneous and retromammary dissection required to create the remote working space, tissue traction through a single-port access channel, CO₂ insufflation, and postoperative drain placement. By contrast, conventional open excision generally involves a more localized dissection directly over or around the lesion. Therefore, the higher 24-hour VAS score in the endoscopic group is biologically plausible and should be discussed explicitly during preoperative counseling. Taken together, the perioperative profile of this approach should be framed as a trade-off rather than as evidence of overall superiority. In this series, the main measurable short-term disadvantages of endoscopic excision were longer operative time, higher 24-hour postoperative pain, and longer hospitalization under our institution-specific drain-based postoperative pathway. The observed reduction in estimated blood loss was small in absolute terms and should not be considered a clinically meaningful advantage. The main potential benefit was higher patient-reported scar satisfaction, breast satisfaction, and psychosocial well-being at 3 months, plausibly related to concealment of the incision away from the visible breast surface. Therefore, the practical balance appears to be greater early perioperative burden in exchange for potentially improved patient-reported cosmetic and psychosocial outcomes. This balance may be acceptable for carefully selected patients who strongly prioritize avoidance of a visible breast-surface scar, but it depends on individual preferences, lesion characteristics, institutional postoperative pathways, costs, and longer-term outcomes that were not assessed in this small cohort. Cost is another important component of this trade-off. At our institution during the study period, the endoscopic procedure required additional direct procedural charges compared with conventional open excision, including 800 RMB, approximately US$111, for endoscopic instrumentation, 850 RMB, approximately US$118, for disposable single-port endoscopic consumables, and 50 RMB, approximately US$7, for intraoperative ultrasonographic guidance. Thus, the additional charge directly attributable to ultrasonographic guidance was small, whereas most of the added procedure-related charge was related to endoscopic instruments and disposable single-port consumables. We did not compare total patient-borne expenses between groups because individual medical insurance reimbursement rates varied across patients, making final out-of-pocket costs not directly comparable. These cost considerations should be discussed during preoperative counseling, particularly when patients weigh the value of scar concealment and cosmetic satisfaction against greater early postoperative pain, longer operative time, institution-specific hospitalization, and additional procedural charges. Although incision lengths were numerically similar between groups (4.2 ± 0.8 cm vs. 3.8 ± 1.2 cm), the aesthetic rationale of the transaxillary endoscopic approach relates primarily to incision location and visible scar burden rather than incision length alone. The transaxillary incision is placed within the natural axillary crease and away from the visible breast surface, whereas open excision generally requires a periareolar or lesion-overlying breast incision. For young women who prioritize breast surface appearance, concealment of the scar within the axilla may be more meaningful than the absolute incision length. This distinction may help explain the higher 3-month scar satisfaction scores observed in the endoscopic group, although this finding should be interpreted cautiously because of the small sample size and non-randomized treatment allocation. This consideration may be particularly relevant in patients with multiple fibroadenomas or lesions located far from the axillary access point. When multiple lesions are distributed in different regions of the breast and cannot be adequately accessed through a single open incision, conventional open surgery may require more than one breast-surface incision. In selected patients, a transaxillary endoscopic approach may allow multiple sonographically identifiable lesions to be removed through a single concealed axillary incision, thereby potentially reducing the number of visible breast-surface scars. However, lesion location remains an important technical consideration. Inner quadrant and lower inner quadrant lesions are farther from the axillary incision and may require a longer dissection path, broader retromammary working-space creation, and more frequent ultrasonographic confirmation of lesion orientation. In the present cohort, three endoscopic patients had upper inner quadrant lesions and one had a lower inner quadrant lesion, all of which were successfully excised without conversion or an additional breast-surface incision. In our operative setup, the ipsilateral arm was wrapped with sterile drapes and suspended to the anesthesia frame to increase the working space for endoscopic instruments, and the instruments used had sufficient length to reach these more distant lesions. Nevertheless, this potential benefit depends on lesion location, sonographic visibility, and the feasibility of safe remote dissection, and should not be interpreted as a general indication for all multiple fibroadenomas. Lesion size is also relevant to patient selection. Smaller fibroadenomas may be more difficult to localize and manipulate through a remote transaxillary endoscopic approach because direct palpation is limited after creation of the working space. In this study, only lesions with a maximum diameter of at least 1.0 cm were included, and all endoscopically treated lesions were clearly identifiable on ultrasonography. Therefore, our data cannot establish a validated minimum size threshold. In our current practice, lesions smaller than 1.0 cm, poorly visible lesions, or lesions with uncertain intraoperative sonographic localization are not routinely preferred for transaxillary endoscopic excision. These lesions may be better managed by observation, ultrasound-guided vacuum-assisted excision, or conventional open excision, depending on clinical indication and patient preference. The role of endoscopic excision should also be considered in the broader context of minimally invasive treatment for breast fibroadenoma and other benign breast lesions [14]. Image-guided percutaneous techniques, particularly vacuum-assisted excision, are widely used for selected benign breast lesions and may offer rapid recovery with minimal visible scarring [15–19]. In routine practice, these methods are often favored for smaller lesions, although selected larger lesions have also been treated with vacuum-assisted excision. Other non-excisional image-guided options, such as high-intensity focused ultrasound, have also been explored for fibroadenoma treatment [20]. Endoscopic excision may occupy a different technical niche, particularly when en bloc removal, lesion depth, or avoidance of a visible breast incision is a major surgical consideration. These approaches therefore represent complementary options, with selection depending on lesion characteristics, patient preference, and surgical goals. In the present cohort, the endoscopic group had a numerically larger maximum tumor diameter than the open group, and the confidence interval was wide. This pattern may suggest treatment selection in routine practice, with endoscopic excision being considered more often in patients with relatively larger lesions or stronger preferences for concealed access. Several limitations should be acknowledged. First, the retrospective single-center design and small sample size limit generalizability and preclude causal inference. The sample was determined by the number of eligible consecutive cases, and no formal a priori power calculation was performed; accordingly, confidence intervals for several outcomes, particularly complication endpoints, were wide. Second, although baseline characteristics were generally comparable, the numerical tendency toward larger tumors in the endoscopic group suggests potential treatment selection and residual confounding. Third, follow-up was limited to three months, which is insufficient to assess the durability of scar satisfaction, long-term contour stability, and later patient-reported adaptation. Fourth, length of hospital stay was strongly influenced by local postoperative management protocols. Open excision patients were admitted mainly for short-term observation of early complications, whereas endoscopic patients were routinely managed with postoperative drainage because of the potential dead space created by the retromammary working space. Discharge after endoscopic excision was linked to drain output and drain removal criteria. Therefore, length of stay in this study should not be interpreted as a universal recovery endpoint, and its generalizability is limited in healthcare systems where benign breast surgery is routinely performed as an outpatient or same-day procedure. Future studies should further investigate whether postoperative drainage volume can be used to guide individualized drain removal timing after endoscopic excision, which may help shorten unnecessary hospitalization while maintaining safety. Fifth, although we reported the additional procedure-related charges associated with the endoscopic approach at our institution, we did not perform a formal cost-effectiveness analysis. Total patient-borne expenses were not compared because individual medical insurance reimbursement rates varied across patients, which limited the comparability of final out-of-pocket costs. Single-port transaxillary endoscopic excision with intraoperative ultrasonographic guidance was technically feasible in this small retrospective cohort of selected patients with breast fibroadenoma. The technique enabled complete excision without conversion or sonographically visible residual lesions. Compared with open excision, however, it involved longer operative time, greater early postoperative pain, and longer institution-specific hospitalization, while the observed reduction in estimated blood loss was small and of limited clinical relevance. This approach may be considered for carefully selected patients who strongly prioritize avoidance of a visible breast-surface scar, provided that the short-term perioperative trade-offs, potential additional costs, and uncertainty of longer-term outcomes are discussed during preoperative counseling. Larger prospective studies are needed to define patient selection, cost-effectiveness, and longer-term patient-reported outcomes.